Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 389.00
Bid: 380.00
Ask: 398.00
Change: -6.00 (-1.52%)
Spread: 18.00 (4.737%)
Open: 389.00
High: 389.00
Low: 389.00
Prev. Close: 395.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 Oct 2017 18:31

RNS Number : 8770S
MaxCyte, Inc.
05 October 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

MaxCyte, Inc.

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Wendell M. Starke

City and country of registered office (if applicable)

Gainesville, Georgia USA

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

Sept 27, 2017

6. Date on which issuer notified (DD/MM/YYYY):

Sept 27, 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.70%

1,879,083

0%

3.70%

1,879,083

50,836,962

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Common

1,379,149

499,934*

2.7129%

.9834%

SUBTOTAL 8. A

1,879,083

3.70%

* Held in Pensco Trust Co, Roth IRA account for Wendell M. Starke

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

N/A

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Wendell M. Starke

3.70%

-

3.70%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Indirect voting shares are held by Pensco Trust Co. Denver, Colorado in Wendell M. Starke Roth IRA account

 

Place of completion

Gainesville, Georgia 30501

Date of completion

September 27, 2017

 

Annex: Notification of major holdings (to be filed with the FCA only)

A: Identity of the person subject to the notification obligation

Full name (including legal form for legal entities)

Wendell M. Starke

Contact address (registered office for legal entities)

850 Holley Drive

Gainesville, Georgia 30501

E-Mail

wendell.starke@gmail.com

Phone number / Fax number

404-229-7769

Other useful information

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name

Wendell M. Starke

Contact address

850 Holley Drive

Gainesville, Georgia 30501

E-Mail

wendell.starke@gmail.com

Phone number / Fax number

404-229-7769

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

 

 

Please send the completed form together with this annex to the FCA at the following email

address: Majorshareholdings@fca.org.uk. Please send in Microsoft Word format if possible.

Notes

 

i Please note that national forms may vary due to specific national legislation (Article 3(1a) of Directive 2004/109/EC) as for instance the applicable thresholds or information regarding capital holdings.

 

ii Full name of the legal entity and further specification of the issuer or underlying issuer, provided it is reliable and accurate (e.g. address, LEI, domestic number identity). Indicate in the relevant section whether the issuer is a non UK issuer.

 

iii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiring of financial instruments) or acting in concert.

 

iv This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h)/ Article 10 (b) to (h) of Directive 2004/109/EC; (c) all parties to the agreement referred to in Article 10 (a) of Directive 2004/109/EC (DTR5.2.1 (a)) or (d) the holder of financial instruments referred to in Article 13(1) of Directive 2004/109/EC (DTR5.3.1).

 

As the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party) the standard form does not provide for a specific method how to notify cases of acting in concert.

 

In relation to the transactions referred to in points (b) to (h) of Article 10 of Directive 2004/109/EC (DTR5.2.1 (b) to (h)), the following list is provided as indication of the persons who should be mentioned:

 

- in the circumstances foreseen in letter (b) of Article 10 of that Directive (DTR5.2.1 (b)), the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

 

- in the circumstances foreseen in letter (c) of Article 10 of that Directive (DTR5.2.1 (c)), the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

 

- in the circumstances foreseen in letter (d) of Article 10 of that Directive (DTR5.2.1 (d)), the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

 

- in the circumstances foreseen in letter (e) of Article 10 of that Directive (DTR5.2.1 (e)), the controlling natural person or legal entity and, provided it has a notification duty at an individual level under Article 9 (DTR 5.1), under letters (a) to (d) of Article 10 of that Directive (DTR5.2.1 (a) to (d)) or under a combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in letter (f) of Article 10 of that Directive (DTR5.2.1 (f)), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

 

- in the circumstances foreseen in letter (g) of Article 10 of that Directive (DTR5.2.1 (g)), the natural person or legal entity that controls the voting rights;

 

- in the circumstances foreseen in letter (h) of Article 10 of that Directive (DTR5.2.1 (h)), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion (e.g. management companies).

 

v Applicable in the cases provided for in Article 10 (b) to (h) of Directive 2004/109/EC (DTR5.2.1 (b) to (h). This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to in Article 10 of that Directive (DTR5.2) unless the percentage of voting rights held by the shareholder is lower than the lowest notifiable threshold for the disclosure of voting rights holdings in accordance with national practices (e.g. identification of funds managed by management companies).

 

vi The date on which threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.

 

vii The total number of voting rights shall be composed of all the shares, including depository receipts representing shares, to which voting rights are attached even if the exercise thereof is suspended.

 

viii If the holding has fallen below the lowest applicable threshold in accordance with national law, please note that it might not be necessary in accordance with national law to disclose the extent of the holding, only that the new holding is below that threshold.

 

ix In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.

 

x Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

 

xi If the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].

 

xii In case of cash settled instruments the number and percentages of voting rights is to be presented on a delta-adjusted basis (Article 13(1a) of Directive 2004/109/EC) (DTR 5.3.3.A).

 

xiii If the person subject to the notification obligation is either controlled and/or does control another undertaking then the second option applies.

 

xiv The full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity has to be presented also in the cases, in which only on subsidiary level a threshold is crossed or reached and the subsidiary undertaking discloses the notification as only thus the markets get always the full picture of the group holdings. In case of multiple chains through which the voting rights and/or financial instruments are effectively held the chains have to be presented chain by chain leaving a row free between different chains (e.g.: A, B, C, free row, A, B, D, free row, A, E, F etc.).

 

xv The names of controlled undertakings through which the voting rights and/or financial instruments are effectively held have to be presented irrespectively whether the controlled undertakings cross or reach the lowest applicable threshold themselves.

 

xvi Example: Correction of a previous notification.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFFDIALEIID
Date   Source Headline
8th May 20247:05 amRNSFiling of Form 10-Q
8th May 20247:00 amRNSFirst Quarter Results
3rd May 20247:00 amRNSNotice of AGM
1st May 20245:04 pmRNSTotal Voting Rights
10th Apr 20241:05 pmRNSNotice of Results
3rd Apr 20247:00 amRNSTotal Voting Rights and Block Listing Return
2nd Apr 20241:05 pmRNSSigning of Strategic Platform License
2nd Apr 20247:00 amRNSExercise of options and PDMR dealing
20th Mar 202410:16 amRNSGrant of Options, RSUs and PSUs and PDMR Dealing
20th Mar 202410:05 amRNSGrant of Options, RSUs and PSUs and PDMR Dealing
13th Mar 20247:05 amRNSFiling of form 10-K for FY ended December 31, 2023
13th Mar 20247:00 amRNSReports Q4 & FY 2023 Financial Results
6th Mar 20248:58 amRNSTR-1: Notification of major holdings
5th Mar 20247:00 amRNSPreliminary FY Results & 2024 Guidance
1st Mar 20245:57 pmRNSTotal Voting Rights
29th Feb 20249:21 amRNSExercise of options and PDMR dealing
26th Feb 20247:00 amRNSTR-1: Notification of major holdings
9th Feb 20241:05 pmRNSNotice of Results
1st Feb 20249:24 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
30th Jan 20242:29 pmRNSHolding(s) in Company
30th Jan 20241:05 pmRNSSigning of Strategic Platform License
29th Jan 20244:52 pmRNSTR-1: Notification of major holdings
29th Jan 20247:00 amRNSFiling of Form 8-K
23rd Jan 20241:05 pmRNSSigning of Strategic Platform License
9th Jan 20247:00 amRNSPreliminary Unaudited Q4 and FY 2023 Results
5th Jan 20247:00 amRNSGrant of Options and PDMR Dealing
3rd Jan 20241:05 pmRNSSigning of Strategic Platform License
2nd Jan 20249:23 amRNSTotal Voting Rights
2nd Jan 20247:00 amRNSConfirmation of Board change
29th Dec 20237:00 amRNSExercise of options and PDMR dealing
12th Dec 20237:00 amRNSCEO Transition and Revenue Guidance Update
7th Dec 20239:50 amRNSExercise of options and PDMR dealing
4th Dec 20237:00 amRNSExercise of options and PDMR dealing
1st Dec 20235:43 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of options and PDMR dealing
17th Nov 20237:00 amRNSExercise of options and PDMR dealing
16th Nov 20231:05 pmRNSMaxCyte Joins the Alliance for mRNA Medicines
9th Nov 20237:01 amRNSFiling of Form 10-Q
9th Nov 20237:00 amRNSThird Quarter Results
7th Nov 20237:00 amRNSParticipation in Upcoming Investor Conferences
1st Nov 20231:12 pmRNSTotal Voting Rights
5th Oct 20237:00 amRNSPreliminary Q3 Revenue & FY Revenue Guidance
2nd Oct 20234:03 pmRNSTotal Voting Rights
13th Sep 20232:28 pmRNSTR-1: Notification of major holdings
12th Sep 20231:21 pmRNSTR-1: Notification of major holdings
5th Sep 20234:17 pmRNSTR-1: Notification of major holdings
5th Sep 20231:05 pmRNSBaird Global Healthcare Conference Participation
4th Sep 20231:32 pmRNSTR-1: Notification of major holdings
4th Sep 20237:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.